| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |